The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

The expanded recommendation is good news for Moderna, Pfizer, and GSK, which all sell RSV vaccines for older adults. Moderna ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60 ...

A newly configured federal vaccine panel's June 25 action is expected to improve options to protect infants from potentially ...

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans ...

Possible “tripledemic” Some experts are concerned that RSV, coupled with COVID and the flu, may result in what’s being dubbed as a “tripledemic” this winter.

A quadruple whammy of viruses – flu, COVID, norovirus, and respiratory syncytial virus, or RSV – is hitting the U.S. as the year comes to a close. The Centers for Disease Control and ...

And respiratory syncytial virus (RSV) is still putting people in the hospital, albeit at lower levels than flu or COVID. Yet despite all the sniffles, it’s shaping up to be a fairly typical year ...

RSV: symptoms and how long it's contagious Respiratory syncytial virus, or RSV, is another respiratory illness. The CDC said the symptoms of RSV are similar to those of the flu or COVID.

So far there have been 32 flu-related deaths in Pennsylvania for the 2024-25 season. For RSV, 4,103 cases were reported last week, up 14% from the previous week.

Those flu and RSV rates are similar to what was seen about this time last year, but COVID is trailing, at about half its seasonal rate. Also, COVID hospitalization rates are less than half of what ...

Flu season might soon be dubbed “sick season” as a cocktail of respiratory viruses, including influenza, COVID-19, and respiratory syncytial virus (RSV), surges across the United States.